Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 293010, 15 pages
http://dx.doi.org/10.1155/2013/293010
Research Article

A Two-Level Model for the Analysis of Syndrome of Acute Ischemic Stroke: From Diagnostic Model to Molecular Mechanism

1Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China
2Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100029, China
3Beijing University of Chinese Medicine, Beijing 100029, China

Received 10 January 2013; Revised 1 March 2013; Accepted 1 March 2013

Academic Editor: Zhaoxiang Bian

Copyright © 2013 Wen Dai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Zhang, A. M. Chapman, M. Plested, D. Jackson, and F. Purroy :, “The incidence, prevalence, and mortality of stroke in France, Germany, Italy, Spain, the UK, and the US: a literature review,” Stroke Research and Treatment, vol. 2012, Article ID 436125, 11 pages, 2012. View at Publisher · View at Google Scholar
  2. K. Strong, C. Mathers, and R. Bonita, “Preventing stroke: saving lives around the world,” The Lancet Neurology, vol. 6, no. 2, pp. 182–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. C. C. Liao, J. G. Lin, C. C. Tsai et al., “An investigation of the use of traditional Chinese medicine in stroke patients in Taiwan,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 387164, 8 pages, 2012. View at Publisher · View at Google Scholar
  4. Y. I. Shin, C. Y. Yang, M. C. Joo, S. G. Lee, J. H. Kim, and M. S. Lee, “Patterns of using complementary and alternative medicine by stroke patients at two university hospitals in Korea,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 2, pp. 231–235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Liu, B. Wu, W. Z. Wang, L. M. Lee, S. H. Zhang, and L. Z. Kong, “Stroke in China: epidemiology, prevention, and management strategies,” The Lancet Neurology, vol. 6, no. 5, pp. 456–464, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Morley, K. Jackson, and G. E. Mead, “Post-stroke fatigue: an important yet neglected symptom,” Age and Ageing, vol. 34, no. 3, p. 313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Goto, N. Satoh, Y. Hayashi et al., “A Chinese herbal medicine, tokishakuyakusan, reduces the worsening of impairments and independence after stroke: a 1-year randomized, controlled trial,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 194046, 6 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Kleindorfer, J. Khoury, J. P. Broderick et al., “Temporal trends in public awareness of stroke: warning signs, risk factors, and treatment,” Stroke, vol. 40, no. 7, pp. 2502–2506, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. Williams, W. D. Rosamond, and D. L. Morris, “Stroke symptom attribution and time to emergency department arrival: the delay in accessing stroke healthcare study,” Academic Emergency Medicine, vol. 7, no. 1, pp. 93–96, 2000. View at Google Scholar · View at Scopus
  10. C. M. C. Allen, “Differential diagnosis of acute stroke: a review,” Journal of the Royal Society of Medicine, vol. 77, no. 10, pp. 878–881, 1984. View at Google Scholar · View at Scopus
  11. C. S. Kidwell and S. Warach, “Acute ischemic cerebrovascular syndrome: diagnostic criteria,” Stroke, vol. 34, no. 12, pp. 2995–2998, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. K. S. Yew and E. Cheng, “Acute stroke diagnosis,” American Family Physician, vol. 80, no. 1, pp. 33–40, 2009. View at Google Scholar · View at Scopus
  13. X. Shi and J. Li, “Clinical research on acupuncture treatment of stroke disease,” Shanghai Journal of Acupuncture and Moxibustion, vol. 11, no. 4, pp. 4–7, 1992. View at Google Scholar
  14. G. Tao and X. Du, “The significance of reinforcing Qi activating blood in the treatment of ischemic stroke,” Journal of Shaanxi College of Traditional Chinese Medicine, vol. 21, no. 3, pp. 1–2, 1998. View at Google Scholar
  15. Y. Liu, H. J. Yin, D. Z. Shi, and K. J. Chen, “Chinese herb and formulas for promoting blood circulation and removing blood stasis and antiplatelet therapies,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 184503, 8 pages, 2012. View at Publisher · View at Google Scholar
  16. F. Cheng, X. Wang, Y. Lu, X. Zhong, Y. Zhao, and Q. Wang, “Chinese medicine injection qingkailing for treatment of acute ischemia stroke: a systematic review of randomized controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 213172, 7 pages, 2012. View at Publisher · View at Google Scholar
  17. China SAoTCMotPsRo, “A standard diagnosis for stroke in TCM (for trial implementation),” Journal of Beijing University of TCM, vol. 17, pp. 64–66, 1994. View at Google Scholar
  18. H. J. Kim, H. S. Bae, S. U. Park, S. K. Moon, J. M. Park, and W. S. Jung, “Clinical approach to the standardization of oriental medical diagnostic pattern identification in stroke patients,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 768492, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Jiang, S. Zhou, R. Zhao, and D. Wu, “Investigation on quantitative diagnosis of stroke with Qi deficiency and blood stasis,” International Journal of Traditional Chinese Medicine, vol. 33, no. 2, pp. 143–145, 2011. View at Google Scholar
  20. Y. Gao, B. Ma, Q. Liu, and Y. Wang :, “Methodological study and establishment of the diagnostic Scale for TCM syndromes of ischemic stroke,” Journal of Traditional Chinese Medicine, vol. 52, no. 24, pp. 2097–2101, 2011. View at Google Scholar
  21. D. T. Laskowitz, S. E. Kasner, J. Saver, K. S. Remmel, and E. C. Jauch, “Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study,” Stroke, vol. 40, no. 1, pp. 77–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Lu, J. Chen, H. Zhao et al., “In silico syndrome prediction for coronary artery disease in traditional chinese medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 142584, 11 pages, 2012. View at Publisher · View at Google Scholar
  23. B. E. Boser, I. M. Guyon, and V. N. Vapnik, “Training algorithm for optimal margin classifiers,” in Proceedings of the 5th Annual ACM Workshop on Computational Learning Theory, pp. 144–152, July 1992. View at Scopus
  24. W. Dai, J. Chen, and P. Lu, “Pathway Pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula,” Molecular BioSystems, vol. 9, pp. 375–385, 2013. View at Publisher · View at Google Scholar
  25. A. Bugrim, T. Nikolskaya, and Y. Nikolsky, “Early prediction of drug metabolism and toxicity: systems biology approach and modeling,” Drug Discovery Today, vol. 9, no. 3, pp. 127–135, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Qiu, K. Wang, and G. Chen, “Retrospective analysis of risk factors in 900 patients with ischemic cerebral stroke of wind-phlegm collateral obstruction syndrome and qi deficiency blood stasis syndrome in Wuhan District,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 31, no. 11, pp. 1483–1486, 2011 (Chinese). View at Google Scholar
  27. R. Batuwita and V. Palade, “FSVM-CIL: Fuzzy support vector machines for class imbalance learning,” IEEE Transactions on Fuzzy Systems, vol. 18, no. 3, pp. 558–571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. C. Chang and C. J. Lin, “LIBSVM: a library for support vector machines,” ACM Transactions on Intelligent Systems and Technology, vol. 2, no. 3, article 27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Akbani, S. Kwek, and N. Japkowicz, “Applying support vector machines to imbalanced datasets,” in Proceedings of the 15th European Conference on Machine Learning (ECML '04), vol. 3201 of Lecture Notes in Computer Science, pp. 39–50, September 2004. View at Scopus
  30. L. Yu and H. Liu, “Feature selection for high-dimensional data: a fast correlation-based filter solution,” in >Proceedings of the 20th International Conference on Machine Learning, pp. 856–863, August 2003. View at Scopus
  31. M. Kubat and S. Matwin, “Addressing the curse of imbalanced training sets: one-sided selection,” in Proceedings of the 14th International Conference on Machine Learning (ICML '97), pp. 179–186, 1997.
  32. P. N. Robinson, S. Köhler, S. Bauer, D. Seelow, D. Horn, and S. Mundlos, “The human phenotype ontology: a tool for annotating and analyzing human hereditary disease,” American Journal of Human Genetics, vol. 83, no. 5, pp. 610–615, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. P. N. Robinson and S. Mundlos, “The human phenotype ontology,” Clinical Genetics, vol. 77, no. 6, pp. 525–534, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. C. Doelken, S. Köhler, S. Bauer et al., “Computational methods for the study of human disease manifestations: the Human Phenotype Ontology,” Medizinische Genetik, vol. 22, no. 2, pp. 221–228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Kanehisa, S. Goto, M. Furumichi, M. Tanabe, and M. Hirakawa, “KEGG for representation and analysis of molecular networks involving diseases and drugs,” Nucleic Acids Research, vol. 38, no. 1, pp. D355–D360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. S. Cline, M. Smoot, E. Cerami et al., “Integration of biological networks and gene expression data using Cytoscape,” Nature Protocols, vol. 2, no. 10, pp. 2366–2382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Ekins, S. Andreyev, A. Ryabov et al., “A combined approach to drug metabolism and toxicity assessment,” Drug Metabolism and Disposition, vol. 34, no. 3, pp. 495–503, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Ito, K. Mori, M. Harada et al., “Serial brain imaging analysis of stroke-like episodes in MELAS,” Brain and Development, vol. 30, no. 7, pp. 483–488, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. F. D. Testai and P. B. Gorelick, “Inherited metabolic disorders and stroke part 1: fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes,” Archives of Neurology, vol. 67, no. 1, pp. 19–24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Y. Jung, H. S. Lee, D. G. Kang et al., “1 H-NMR-based metabolomics study of cerebral infarction,” Stroke, vol. 42, no. 5, pp. 1282–1288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. J. H. Choi, H. Kim, and H. W. Yoo, “Two cases of citrullinaemia presenting with stroke,” Journal of Inherited Metabolic Disease, vol. 29, no. 1, pp. 182–183, 2006. View at Publisher · View at Google Scholar · View at Scopus